Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Powell

Showing results (1021-1030 of 1,069) with videos related to

Pageof 107
Sort By:
Cell Host & Microbe|September 17, 2020
Human B Cell Clonal Expansion and Convergent Antibody Responses to SARS-CoV-2Sandra C A Nielsen, Fan Yang, Katherine J L Jackson, et al.
Nature Communications|February 5, 2025
Atlas of multilineage stem cell differentiation reveals TMEM88 as a developmental regulator of blood pressureSophie Shen, Tessa Werner, Samuel W Lukowski, et al.
Nature Medicine|May 24, 2024
Prediction of recurrence risk in endometrial cancer with multimodal deep learningSarah Volinsky-Fremond, Nanda Horeweg, Sonali Andani, et al.
Obstetrical & Gynecological Survey|December 30, 2025
Adjuvant Chemoradiotherapy Versus Radiotherapy Alone in Women With High-Risk Endometrial Cancer (PORTEC-3): 10-Year Clinical Outcomes and Post Hoc Analysis by Molecular Classification From a Randomized Phase 3 TrialCathalijne C B Post, Stephanie M de Boer, Melanie E Powell, et al.
The Lancet. Oncology|September 8, 2025
Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): 10-year clinical outcomes and post-hoc analysis by molecular classification from a randomised phase 3 trialCathalijne C B Post, Stephanie M de Boer, Melanie E Powell, et al.
Medrxiv : the Preprint Server for Health Sciences|August 26, 2020
SARS-CoV-2 Antibody Responses Correlate with Resolution of RNAemia But Are Short-Lived in Patients with Mild IllnessKatharina Röltgen, Oliver F Wirz, Bryan A Stevens, et al.
Annals of Internal Medicine|September 15, 2025
Identifying Core Clinical Topics and Recommending Core Performance Measures for Internal Medicine Physicians: A Position Paper From the American College of PhysiciansAmir Qaseem, Nick Fitterman, Samantha Tierney, et al.
Clinical & Translational Immunology|June 8, 2026
Myeloid HDAC7 drives liver inflammation and systemic glucose dysregulation during diet-induced obesityYizhuo Wang, Divya Ramnath, Kaustav Das Gupta, et al.
Science (New York, N.Y.)|July 20, 2022
Omicron spike function and neutralizing activity elicited by a comprehensive panel of vaccinesJohn E Bowen, Amin Addetia, Ha V Dang, et al.
Science Immunology|December 8, 2020
Defining the features and duration of antibody responses to SARS-CoV-2 infection associated with disease severity and outcomeKatharina Röltgen, Abigail E Powell, Oliver F Wirz, et al.
Pageof 107

Showing results (1021-1030 of 1,069) with videos related to

Sort By:
Pageof 107
Cell Host & Microbe|September 17, 2020
Human B Cell Clonal Expansion and Convergent Antibody Responses to SARS-CoV-2Sandra C A Nielsen, Fan Yang, Katherine J L Jackson, et al.
Nature Communications|February 5, 2025
Atlas of multilineage stem cell differentiation reveals TMEM88 as a developmental regulator of blood pressureSophie Shen, Tessa Werner, Samuel W Lukowski, et al.
Nature Medicine|May 24, 2024
Prediction of recurrence risk in endometrial cancer with multimodal deep learningSarah Volinsky-Fremond, Nanda Horeweg, Sonali Andani, et al.
Obstetrical & Gynecological Survey|December 30, 2025
Adjuvant Chemoradiotherapy Versus Radiotherapy Alone in Women With High-Risk Endometrial Cancer (PORTEC-3): 10-Year Clinical Outcomes and Post Hoc Analysis by Molecular Classification From a Randomized Phase 3 TrialCathalijne C B Post, Stephanie M de Boer, Melanie E Powell, et al.
The Lancet. Oncology|September 8, 2025
Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): 10-year clinical outcomes and post-hoc analysis by molecular classification from a randomised phase 3 trialCathalijne C B Post, Stephanie M de Boer, Melanie E Powell, et al.
Medrxiv : the Preprint Server for Health Sciences|August 26, 2020
SARS-CoV-2 Antibody Responses Correlate with Resolution of RNAemia But Are Short-Lived in Patients with Mild IllnessKatharina Röltgen, Oliver F Wirz, Bryan A Stevens, et al.
Annals of Internal Medicine|September 15, 2025
Identifying Core Clinical Topics and Recommending Core Performance Measures for Internal Medicine Physicians: A Position Paper From the American College of PhysiciansAmir Qaseem, Nick Fitterman, Samantha Tierney, et al.
Clinical & Translational Immunology|June 8, 2026
Myeloid HDAC7 drives liver inflammation and systemic glucose dysregulation during diet-induced obesityYizhuo Wang, Divya Ramnath, Kaustav Das Gupta, et al.
Science (New York, N.Y.)|July 20, 2022
Omicron spike function and neutralizing activity elicited by a comprehensive panel of vaccinesJohn E Bowen, Amin Addetia, Ha V Dang, et al.
Science Immunology|December 8, 2020
Defining the features and duration of antibody responses to SARS-CoV-2 infection associated with disease severity and outcomeKatharina Röltgen, Abigail E Powell, Oliver F Wirz, et al.
Pageof 107